1.
Cruz Barrios M, Furones Mourelle J. Benefit-risk use of transfer factor (Hebertrans®) in usual medical practice. HS [Internet]. 2019 Apr. 30 [cited 2024 Oct. 18];18(2):235-42. Available from: https://revistahorizonte.ujat.mx/index.php/horizonte/article/view/2918